arbiter
JournalsPricingAccount

Physicians’ preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China

Yali Li et al.

Expert Review of Pharmacoeconomics & Outcomes Research2026https://doi.org/10.1080/14737167.2026.2650162article
ABDC C
Weight
0.50

What the paper says

In China's healthcare setting, beyond the central importance of efficacy, physicians also place great emphasis on affordability and economic value, with marked heterogeneity in preferences depending on background characteristics.

Open paper page →

Cite this paper

https://doi.org/https://doi.org/10.1080/14737167.2026.2650162

Or copy a formatted citation

@article{yali2026,
  title        = {{Physicians’ preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China}},
  author       = {Yali Li et al.},
  journal      = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1080/14737167.2026.2650162},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Physicians’ preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.